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4Department of Clinical Infection, Microbiology and Immunology, Institute of Infection
and Global Health, University of Liverpool, Liverpool, UK1. Summary
Streptococcus pneumoniae is an important cause of bacterial meningitis and pneu-
monia but usually colonizes the human nasopharynx harmlessly. As this niche
is simultaneously populated by other bacterial species, we looked for a role and
pathway of communication between pneumococci and other species. This paper
shows that two proteins of non-encapsulated S. pneumoniae, AliB-like ORF 1 and
ORF 2, bind specifically to peptides matching other species resulting in changes
in the pneumococci. AliB-like ORF 1 binds specifically peptide SETTFGRDFN,
matching 50S ribosomal subunit protein L4 of Enterobacteriaceae, and facilitates
upregulation of competence for genetic transformation. AliB-like ORF 2 binds
specifically peptides containing sequence FPPQS, matching proteins of Prevotella
species common in healthy human nasopharyngeal microbiota. We found that
AliB-like ORF 2 mediates the early phase of nasopharyngeal colonization
in vivo. The ability of S. pneumoniae to bind and respond to peptides of other bac-
terial species occupying the samehost nichemayplay a key role in adaptation to its
environment and in interspecies communication. These findings reveal a comple-
tely new concept of pneumococcal interspecies communication which may have
implications for communication between other bacterial species and for future
interventional therapeutics.2. Introduction
In nature, most bacteria live in multi-species communities known as microbiota,
which when bound together by extracellular matrix are called biofilms. In such
environments, interactions between bacterial species must be important but are
mostly unknown.We knowmore about intraspecies communication via diffusible
signal molecules called autoinducers [1]. Gram-positive bacteria use amino acids
andpeptides as signalmolecules;Gram-negative bacteriauseN-acyl-L-homoserine
lactones (N-AHLs), which mediate quorum sensing leading, for example, to bio-
film development [1]. So far only one cell–cell signalling system, autoinducer-2,
is known to be shared by Gram-positive and Gram-negative bacteria. It has
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to act in interspecies communication [2].
In addition, diverse non-canonical D-amino acids are pro-
duced by several bacterial species during stationary phase of
growth and modulate synthesis of peptidoglycan of the cell
wall [3]. Release of D-amino acids from one species could
affect other bacterial species in the same niche, for example
by inducing biofilm disassembly [3,4]. In Vibrio cholerae, pro-
duction of the D-amino acids seems to be a stress response
enabling the bacteria to respond to environmental changes [5].
Antibioticsmayalsonaturally function in interspecies signal-
ling at subinhibitory concentrations [6]. Antibiotics elicit a stress
response and induce competence for genetic transformation in
Streptococcus pneumoniae, increasing the ability to take up foreign
DNA [7]. Transformation is thought to contribute to genetic
plasticity and therefore adaptation of S. pneumoniae to a hostile
environment by acquiring new, potentially useful, genes [8].
Streptococcus pneumoniae, although a major human patho-
gen, usually lives harmlessly in the human nasopharynx
alongside commensal streptococcal species and other com-
mensal bacterial groups of the nasopharyngeal microbiota,
including Bacteroides, Fusobacterium, Firmicutes, Actinobacteria
and Proteobacteria [9]. Disturbance of the nasopharyngeal eco-
system can lead to abnormal upper-airway colonization, for
example by the normally intestinal colonizers Enterobacteriaceae
[10]. We hypothesized that S. pneumoniae and commensal strep-
tococci must have a way to sense and respond to their
surrounding microbiota and changes in its composition.
A subpopulation of pneumococci lack a polysaccharide
capsule and these non-encapsulated strains are estimated to
make up 0.5–2.2% of S. pneumoniae isolated from sterile sites
and 10–15% of those isolated from the nasopharynx [11–13].
This may be an underestimate as the small colonies they pro-
duce on agar plates might be overlooked in diagnostic
laboratories. We have shown previously that a subset of non-
encapsulated S. pneumoniae carries two extra genes, aliB-like
ORF 1 and ORF 2, in place of capsule genes [14]. We predict
that the aliB-like ORFs encode substrate-binding proteins of
an unknown ATP-binding cassette (ABC) transporter(s). ABC
transporters are important in S. pneumoniae virulence [15].
They generally consist of two permease domains embedded
in the membrane, two ATP-binding domains which provide
the energy for transport and one or more substrate-binding
domains. It is these substrate-binding domains that determine
the specificity of the transporter and bring the substrate to the
permease for uptake. The AliB-like ORFs are named for their
sequence homology to AliB substrate-binding protein of the
Ami-AliA/AliB permease, found in all S. pneumoniae strains,
which is proposed to take up peptides to sense the nutritional
environment [16].
Here, we investigated whether the AliB-like ORFs can bind
and respond to peptides that may be secreted by bacterial
neighbours and so play a role in interspecies communication
and adaptation of S. pneumoniae to its environment.3. Material and methods
3.1. Bacterial culture
Bacteria, stored at 2808C using Protect bacterial preservers
(Technical Service Consultants, Heywood, UK), were grown
on Columbia sheep blood agar (CSBA) plates at 378C, 5%CO2. Overnight cultures were prepared with 3–10 colonies
in 5 ml brain heart infusion (BHI) broth (Becton Dickinson
and Company, le Pont de Claix, France) containing 5% fetal
calf serum (FCS; Biochrom KG, Berlin, Germany).
3.2. Bacterial strains
For Swiss non-encapsulated nasopharyngeal pneumococcal
isolate 110.58, MLST 344 [14], mutants were constructed to
inactivate one or both aliB-like ORFs (see the electronic sup-
plementary material, figure S1). Construction of the mutant
DORF 1 þ 2 was described previously [14]. Restriction
fragment length polymorphism (RFLP)-typing confirmed
transformants originate from strain 110.58 [17]. Southern
blotting and PCR to determine the presence of the ORFs
and transformation of Escherichia coli and S. pneumoniae
were performed as described previously [14,18].
3.2.1. Construction of mutant DORF 1
A1381 bp fragment of dexB of strain 110.58 and chloramphenicol
acetyltransferase (cat) gene fromplasmid pJS3copG7 (kindly pro-
vided by M. Espinosa, Centro de Investigaciones Biologicas,
Madrid, Spain [19]) were inserted into the multiple cloning site
of plasmid pBluescript KSII (Stratagene). Downstream of cat a
1625 bp fragment of aliB-like ORF 1 (lacking the 5’ end) was
inserted. Primers used were: dexB_f145_XbaI, dexB_b1504_
BamHI, cat_Spn_F1_HindIII and cat_Spn_B1_ HindIII [14].
To amplify the 30-end of aliB-like ORF 1, we used primers
110.58_FI3.2_ClaI: CCATCGATGGGTATGCGAAAGTTAAAG
CTC, and 104b832.13_XhoI: CCGCTCGAGTGAGCATTCGATT
CCAGTTTT. The dexB-cat-ORF1 construct was amplified using
primersdexB_f145_XbaIand104b832.13_XhoI andused to trans-
form S. pneumoniae strain 110.58. Recombinant clones were
selected on CSBA plates containing 3 mg l21 chloramphenicol.
PCR confirmed deletion of the 50 end of aliB-like ORF 1 and
real-time RT-PCR confirmed that deletion of aliB-like ORF 1
did not cause a polar effect by altering the expression level of
aliB-like ORF 2.
3.2.2. Construction of mutant DORF 2
A fragment of aliB-like ORF 2 of 110.58 was amplified by PCR
(using primers 104.72_104FI3.6_222311: AGATGCCAAATG
GTTCACGG, and 106_106b832.5_222506: CATCTTTGAGC
ATCTTAGTG) and inserted into pGEM-T Easy Vector (Pro-
mega, Wallisellen, Switzerland). A chloramphenicol cassette
with an ami promoter [16] (primers: Pcat_F_NheI: CTAGCT
AGCgaaaatttgtttgatttttaatggataatgtgatataatgGTTCAACAAAC
GAAAATTGGATAAAGT, and Pn_cat_B1_NheI: ctagctagcCG
GGGCAGGTTAGTGACAT) was cloned into the aliB-like
ORF2 fragment at the NheI restriction site. Strain 110.58
was transformed with the plasmid containing the construct.
Recombinant mutants selected on CSBA plates containing
3 mg l21 chloroamphenicol were analysed by PCR.
Laboratory S. pneumoniae strain R6, used as a control, was
a kind gift from Philippe Moreillon (Centre Hospitalier
Universitaire Vaudois, Lausanne, Switzerland).
3.3. PCR and real-time RT-PCR
To assess the presence of aliB-like ORFs the following primers
were used: forward primer binding in aliB-like ORF 1
rsob.royalsocietypublishing.org
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binding in aliB-like ORF 1 104_b832.14 (50-GCCCTTTGTTA
TACCTAGATGTTTC-30), forward primer binding in aliB-
like ORF 2 104_FI3.6 (50-AGATGCCAAATGGTTCACGG-30)
and reverse primer binding in aliB-like ORF 2 104_b832.10
(50-GAAATCTTTTAACAAATAAGGTCCG-30). PCR was per-
formed using FastStart Taq (Roche): 948C for 5 min, then
948C for 30 s, 508C for 30 s, 728C for 2 min for 30 cycles
then 728C for 10 min.
Gene expression was quantified as described previously
[20] and normalized against 16S using the following primers
and probes: aliB-like ORF 1 forward primer, 50-GGTTCTGC
CTTGAAACATCTAGGT-30; reverse primer, 50-CCAACTTTC
GCCACAACTTCA-30; probe, 6-carboxyfluorescein (6-FAM)-
AAAGGGCAAGGATCC-minor groove binder (MGB);
aliB-like ORF 2 forward primer, 50-CTCTACAGCGGACCTTA
TTTGTTAAAAGA-30; reverse primer, 50-CGGATGGTCAAT
TCTTGGTCTGA-30; probe, 6-FAM-CTTTGTCATGATCATA
GTAATGC-MGB; 16S forward primer, 50-GACGATACATAG
CCGACCTGAGA-30; reverse primer, 50-GTAGGAGTCTGGG
CCGTGTCT-30; probe, 6-FAM-CCAGTGTGGCCGATC-MGB.3.4. Expression and characterization of AliB-like ORF 1
and ORF 2 proteins
Proteins AliB-like ORF 1 and ORF 2 were expressed in E. coli
Rosetta strain (Novagen, Darmstadt, Germany) and purified
using an N-terminal glutathione S-transferase (GST)-tag
(AliB-like ORF 1) or C-terminal His6-tag (AliB-like ORF 2).
SDS-PAGE of the proteins before and after purification is
shown in the electronic supplementary material, figure S2.
For AliB-like ORF 1, forward primer 50-TTTCCCGGGCGAA
AACATTTTCTTATGTTTATG-30 and reverse primer 50-AAA
CTCGAGTTAATGATGATGATGATGATGACCTCATTTTAC
GTGTTTTTCTAAA-30 were used to amplify the full-length
protein excluding the 50 portion encoding the predicted
N-terminal signal peptide. Underlined are the restriction
enzyme sites for XmaI (forward primer) and XhoI (reverse
primer) to enable insertion into the vector. The reverse
primer also encodes His6-tag to provide an alternative protein
purification method. For AliB-like ORF 2, forward primer
50-TTTCCCGGGCGGGACAATCAGGTTCAGATAC-30 and
reverse primer 50-AAACTCGAGTTAATGATGATGATGAT
GATGACCCCATTTGGTCTTAGCTTCTTC-30 were used to
amplify aliB-like ORF 2 without the 50 portion encoding the
predicted N-terminal signal peptide but with an XmaI site,
an XhoI site and a His6-tag. The amplification products were
ligated into expression plasmid pGEX 6p-1which has an ampi-
cillin resistance cassette. The construct was used to transform
the E. coli which harbour a ‘codon plasmid’ adapted for
Gram-positive bacteria which contains a chloramphenicol
selection marker.
Expression of GST-aliB-like ORF1-His6 and GST-aliB-like
ORF2-His6was inducedby isopropyl-b-D-thiogalacto-pyranoside
(IPTG), final concentration 0.1 mM, shaking overnight at 208C.
Native AliB-like ORF 1 was isolated by binding the GST-tag to
GSH-agarose beads (GE Healthcare) and native AliB-like ORF 2
was isolated by binding the His6-tag to nickel-nitrilotriacetic
acid (Ni-NTA) agarose (Qiagen). The proteins were analysed by
SDS-PAGE and shown to contain more than 95% purity of pro-
teins of the expected sizes. The identity of the recombinant
proteins was confirmed by peptide mass fingerprinting.3.5. Identification of peptide ligands of AliB-like ORF 1
and ORF 2
Ligand-binding properties were investigated by incubating
the recombinant proteins with 300 ml infant nasopharyngeal
wash at 378C on a turning wheel for 1 h to allow binding.
Nasopharyngeal wash was obtained in the context of a
larger study approved by the Institutional Ethical Board
(Direktion Lehre und Forschung, Inselspital, University of
Bern, 3010 Bern, Switzerland) and stored at 48C until use.
Written, informed consent was obtained.
The proteins (with ligands bound) were then recovered as
described above using GSH-agarose beads to isolate AliB-like
ORF 1 and Ni-NTA agarose to isolate AliB-like ORF 2. Bound
ligands were released by denaturing the proteins with 8 M
urea. As a negative control, the same procedure was per-
formed in parallel with the exception that no IPTG was
added to the bacteria. Therefore, specific induction of AliB-
like ORF 1 and ORF 2 proteins was avoided in the negative
control, leaving only expression of the E. coli proteins.
Released peptides were isolated using 30 KDa filters then
analysed by LC-MS. Peptide sequencing was performed on
a linear trap quadrupole (LTQ) XL-Orbitrap mass spec-
trometer (Thermo Fisher Scientific, Bremen, Germany) with
a Rheos Allegro nano flow system with AFM flow splitting
(Flux Instruments, Reinach, Switzerland) and nano electro-
spray ion source operated at a voltage of 1.7 kV. Peptide
separation was performed at least twice on a Magic C18
nano column (5 mm, 100 A˚, 0.075  70 mm) at a flow rate of
approximately 400 nl min21, linear gradient (40 min) from 5
to 40% acetonitrile in water and 0.1% (v/v) formic acid.
Data acquisition was in data-dependent mode on the top
five peaks with mass-to-charge ratio (m/z) between 360 and
1400, exclusion 15 s. Survey full scan MS spectra were from
300 to 1800 m/z, resolution set at 60 000 (at 400 m/z). Fragmenta-
tion was by collision-induced dissociation with helium gas in
the LTQ, and spectra were recorded at least once in the LTQ
and once in the orbitrap with resolution 7500. Mascot generic
files (mgf) were created by a pearl script using HARDKLOR soft-
ware, from the *.RAW files [21]. MS/MS data were submitted
to Phenyx (Geneva Bioinformatics) to search all bacteria or
mammalian protein sequences in UniprotKB protein database
(version 2010_12 as of 30 November 2010). Search parameters
were; parent error tolerance 20 ppm, C-terminal cleavage
after amino acids ACDEFGHIKLMNQRSTVWY, dynamic
amino acid modifications of one Oxidation_M and one
deamidation on Asn/Gln, minimal peptide z-score of 5, max
p-value 0.01. The apparent false peptide identification rate
was approximately 30% as estimated by a parallel search
against the reversed database. The discovery of peptides
specifically bound to the AliB-like ORFs was achieved by
manual comparison of the negative with the positive control
or using the software SIEVE (ThermoFisher Scientific).3.6. Tryptophan binding assay
We used 3K Amicon Ultra centrifugal filters (Millipore,
Carrigtwohill, Ireland) to exchange the elution buffer for the
binding assay buffer. Tryptophan fluorescence spectroscopy
assay was performed to measure binding of the recombinant
proteins to the peptide ligands identified by mass spectro-
scopy, and to other peptides (PolyPeptide Group, Strasbourg,
rsob.royalsocietypublishing.org
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assay was performed by adding peptides dissolved in 10 mM
NaH2PO4 to 0.5 mM GST-AliB-like ORF 1-His6 or GST-AliB-
like ORF2-His6 in 1.5 ml 50 mMTris–HCl pH 8.0 to a final con-
centration of 250 mM. Fluorescence was measured by LS-5B
luminescence spectrometer (PerkinElmer, Schwerzenbach,
Switzerland), connected to a graph printer, at excitation wave-
length 295 nm (slit width 5 nm) and emission wavelength
330 nm (slit width 10 nm) while stirring continuously at 218C.
3.7. Transformation assay
To compare transformation rates of 110.58 and its mutants,
bacteria were grown to an OD600nm of 0.15 in BHI containing
5% FCS. A total of 0.5 ml of the culture was transferred to
9.5 ml trypticase soy broth (TSB) competence medium pH
8.0 prewarmed to 308C and incubated for 15 min. Compe-
tence-stimulating peptide 2 (CSP 2; EMRISRIILDFLFLRKK)
was added to final concentration 100 ng ml21 and the culture
incubated for 15 min at 308C. One microgram of chromoso-
mal DNA from streptomycin resistant strain 104.37 was
added and the culture incubated for 60 min at 308C, then
90 min at 378C. Serial dilutions in PBS were plated onto
CSBA plates with and without 200 mg ml21 streptomycin.
After overnight incubation, the number of colonies was
counted and the transformation rate calculated.
3.8. Competence gene expression
Competence development was measured using a modified
version of the method of Caymaris et al. [24]. Stock cultures
were grown at 378C in TSB pH 8 to OD600nm of 0.2 and
frozen with 15% glycerol at 2808C. Thawed cultures were
used to inoculate (1 : 10) C þ Y medium containing luciferin
(0.18 mg ml21). Three hundred microlitres per well was
added to a 96-well plate. To determine the synergistic effect
of AliB-like ORF 1 ligand (SETTFGRDFN) on CSP 2-mediated
competence induction, the bacteriawere pre-treated for 30 min
with AliB-like ORF 1 ligand (100 mg ml21) before addition of
100 ng ml21 CSP 2. To measure competence, we used ssbB::luc
transcriptional fusion (kindly provided byM. Prudhomme and
J. P. Claverys, Centre National de la Recherche Scientifique,
Toulouse, France), which reports competence through light
emission by luciferase [7]. Relative luminescence unit and
OD values were recorded throughout incubation at 378C (in
a Varioskan Flash luminometer; Thermo Fisher Scientific,
Zurich, Switzerland). Area under the curve (AUC) was
calculated using GRAPHPAD PRISM 5.
3.9. Adherence assay
Adherence to an epithelial cell line was performed as
described previously [14] with the following differences:
Detroit 562 nasopharyngeal epithelial cells (ATCC CCL-138)
were cultured on glass coverslips in a 24-well tissue culture
plate and the number of bacteria adhered per Detroit cell
was counted by microscopy following Giemsa staining.
A total of 4  105 cells/well in Minimum Essential Mediumþ
Earle’s salts (MEM) containing 10% FCS, 2 mM L-glutamine,
1.5 g l21 sodium bicarbonate, 0.1 mM non-essential amino
acids and 1 mM sodium pyruvate (Gibco, UK) were cultured
until reaching complete confluence at 378C in 5% CO2. Strep-
tococcus pneumoniae strain 110.58 and its AliB-like ORF 1 and2 deficient mutant grown in BHI broth containing 5% FCS to
the logarithmic phase were washed in MEM then resus-
pended to give 107 bacteria in 0.5 ml MEM, which was
added per well of washed Detroit cells (the concentration of
bacteria was confirmed by plating out appropriate dilutions
of the inoculum). The bacteria were centrifuged onto the
cells at 390g for 5 min at room temperature. After the 1 h
incubation of the cells with the bacteria at 378C and five
washes with PBS, the cells were fixed by a 3 min incubation
with 500 ml methanol, which was then removed. Four hun-
dred microlitres of Giemsa stain (1 : 7 dilution of Giemsa in
0.007 M phosphate buffer, pH 6.8) was then added and incu-
bated for 30 min and then removed. Following a 2 min wash
with double distilled water, 500 ml 0.01% acetic acid was
added and then immediately removed. This was repeated
four times followed by a 2 min wash with double distilled
water. When dry, the coverslip was mounted onto a micro-
scope slide, viewed microscopically and photographed to
allow counting of the number of bacteria adhered per cell.
3.10. Growth assays
To test the effect of the ORF 1 and ORF 2 ligand peptides on
growth, pneumococci were streaked onto CSBA plates and
cultured for 1 day at 378C in a 5% CO2-enriched atmosphere.
The resulting colonies were used to inoculate 5 ml BHI con-
taining 5% FCS and cultured overnight at 378C in a
waterbath until OD600nm was greater than 0.5. Two hundred
microlitres of the overnight culture was added to 5 ml BHI
containing 5% FCS with or without 1 mg ml21 of the peptide
ligand. After 4.5 h, serial dilutions were made and plated out
on CSBA plates containing 500 mg ml21 kanamycin. Colonies
were counted the next day.
To test the effect of E. coli bacteria on pneumococcal
growth, E. coliwere streaked onto LB plates and S. pneumoniae
strainswere plated onto CSBA plates and cultured overnight at
378C in a 5% CO2-enriched atmosphere. Overnight cultures of
S. pneumoniaewere prepared by inoculating 5 ml BHI with 5%
FCS with colonies from the plate and by culturing the E. coli in
LB broth with shaking. Two hundred microlitres of the over-
night pneumococcal culture was then used to inoculate 5 ml
BHI with 5% FCS plus either 200 ml of the E. coli overnight cul-
ture or 200 ml of LB broth. After 4.5 h, serial dilutions were
made and plated out on CSBA plates containing 500 mg ml21
kanamycin (except for control strain R6 which was plated
on CSBA plates). After overnight incubation, the colonies
were counted.
3.11. Nasopharyngeal colonization study
Female outbred MF1 mice were used. All protocols were
approved by appropriate UK Home Office licensing autho-
rities and by the University of Liverpool Ethical Committee.
Mice were 8–10 weeks old when infected and weighed
30–35 g (Harlan, Bicester, UK). The mice were specific patho-
gen free but not germ free and therefore carrying their
natural microflora. The mice were lightly anaesthetized with
2.5% (vol/vol) fluothane (AstraZeneca, Macclesfield, UK)
over oxygen (1.5–2 l min–1), and 10 ml PBS containing 5 
105 cfu bacteria administered into the nostrils. The inoculum
dose was confirmed by viable count after plating on blood
agar plates following infection. At intervals following infec-
tion, groups of mice were killed by cervical dislocation, and
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Figure 1. (Caption opposite.)
Figure 1. (Opposite.) Identification of AliB-like ORF 1 ligand SETTFGRDFN and
AliB-like ORF 2 ligands FPPQSV and FPPQS. (a) AliB-like ORF 1 ligand: extracted
ion chromatogram of the doubly charged peptide ion with mass-to-charge ratio
(m/z) of 587.26201 (retention time (RT) 47.36 min) with mass tolerance of
+1 ppm from the negative control (i) and positive sample (ii), intensity
scale set at the same level. (b) Representative fragment mass spectrum acquired
in the linear trap quadrupole (LTQ) iontrap and sequence interpretation by PHENYX
software. Only the y-ion series (fragments appearing to extend from the car-
boxyl terminus) is annotated. (Individual peaks corresponding to the initial
two amino acids S and E at the amino terminus are not visible in the y-ion
series and are therefore not annotated but SE is the mass difference between
the last detectable y-ion at 957.59 and the singly charged molecular ion of
1173.517.) (c) AliB-like ORF 2 ligands: extracted ion chromatogram of the
singly charged peptide ions with mass-to-charge ratio (m/z) of 575.27934
(RT ¼ 45.45 min, corresponding to sequence FPPQS) and 674.34844 (RT ¼
51.05 min, sequence FPPQSV) with mass tolerance of+2 ppm from the nega-
tive control (i) and positive sample (ii), intensity scale set at the same level. A
representative fragment mass spectrum acquired in Fourier transformation (FT)
mode, resolution of 7500, of peptides 575 (d ) and 674 (e) is shown. Manual
interpretation of the fragment peaks is shown using italic letters for the
b-ion (fragments appearing to extend from the amino terminus) and non-
italic letters for the y-ion series. Confirmation of correct interpretation was
achieved with fragment spectra of synthetic peptides (electronic supplementary
material, figure S3).
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placed in 5 ml of sterile PBS, weighed and homogenized by
an Ultra-Turrax hand-held homogenizer (IKA, Germany).
Colony-forming units in homogenates were determined by
serial dilution in sterile PBS and plating onto agar plates
(Oxoid, Basingstoke, UK) with 5% (vol/vol) horse blood.3.12. Genetic comparison
Genetic comparisons between species were made by per-
forming BLAST searches using the NCBI website (http://
www.ncbi.nlm.nih.gov/BLAST/).3.13. Statistical analysis
Student t-tests were performed to obtain p-values.4. Results
To find the ligands of S. pneumoniae proteins AliB-like ORF 1
and ORF 2, we expressed recombinant proteins and incubated
them in human nasopharyngeal washings and then released
bound peptide with urea. LC-MS analysis identified a single
peptide ligand for AliB-like ORF 1 with the sequence:
SETTFGRDFN (figure 1a,b). For AliB-like ORF 2, two peptide
ligands were identified: FPPQSV and FPPQS (figure 1c–e and
electronic supplementary material, figure S3). BLAST analysis
indicated that AliB-like ORF 1 ligand is in the 50S ribosomal
subunit protein L4 of Enterobacteriaceae, including Salmonella
enterica, E. coli, Serratia symbiotica and Klebsiella pneumoniae.
The sequence of the AliB-like ORF 2 ligand FPPQSV also has
multiple bacterial matches including ribosome-associated
GTPase EngA of the human commensal Prevotella salivae and
sulfate adenylyltransferase of Prevotella tannerae.
Tryptophan fluorescence binding assays confirmed that the
ligand of AliB-like ORF 1 is SETTFGRDFN (figure 2a). (Testing
of a longer peptide containing the AliB-like ORF 1 ligand
sequence was prevented by its insolubility.) Binding was
specific as a peptide with one amino acid difference (SETTF-
GREFN), the equivalent sequence in Haemophilus influenzae, a
human pathogen which colonizes the nasopharynx, did
not bind (figure 2b). Also, AliB-like ORF 2 ligand FPPQSV
(figure 2c) and the putative ligand for real-AliB (LRRASLG)
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Figure 2. Binding of recombinant AliB-like ORFs to their ligands. Binding of
recombinant AliB-like ORF 1 (a–d ) and AliB-like ORF 2 (e– k) to synthetic
peptides was determined by measuring changes in intrinsic protein fluor-
escence using tryptophan fluorescence. A drop in fluorescence indicates
binding. Peptide sequences are indicated above the arrows marking the
moment of their addition to the protein.
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phan fluorescence assay also confirmed that the ligand of
AliB-like ORF 2 is FPPQSV (figure 2e) with a positive, butweaker, signal with FPPQS (figure 2f). AliB-like ORF 2 was
more promiscuous than AliB-like ORF 1 as AliB-like ORF 2
protein also bound FPPQSI (P. tannerae, putative ABC transpor-
ter) (figure 2g) and FPPQNV (human Deltex 1) (figure 2h)
though it did not bind the completely unrelated peptides of
the AliB-like ORF 1 ligand (figure 2i) or the ligand for real-
AliB (LRRASLG) (figure 2j). Binding of AliB-like ORF 2 protein
was also observed with peptide IEAFPPQSVKGK (figure 2k)
representing AliB-like ORF 2 ligand (underlined) flanked by
three amino acids either side that are found adjacent to the
ligand sequence in P. salivae GTPase EngA.
To enable functional analyses of the AliB-like ORFs, we
made mutants where one or both ORFs were disrupted (see
the electronic supplementary material, figure S1 for genetic
structures). Since AliB-like ORF 1 bound a peptide fragment
that is found in Enterobacteriaceae, which are not part of the
normal nasopharyngeal microbiota, we speculated that such
binding may elicit a stress response. Streptococcus pneumoniae
are naturally competent for genetic transformation and being
able to take upDNA in a hostile environmentmay confer a sur-
vival advantage. Transformation rate was therefore compared
in the wild-type and mutant strains. Wild-type strain 110.58
had a transformation rate 5.3-fold higher than that of the
mutant lacking both ORFs, and 20.2-fold higher than that
of the mutant lacking ORF 1 only (figure 3a). The mutant
lacking only ORF 2 had a higher transformation rate than
the wild-type strain. We confirmed the role of AliB-like ORF
1 in competence by investigating expression of late competence
gene ssbB in wild-type strain 110.58 and its DORF 1 mutant
(figure 3b). We observed no increase in spontaneous compe-
tence induction by incubating with AliB-like ORF 1 ligand
SETTFGRDFNwithout adding competence-stimulatingpeptide
(CSP) 2, the peptide released by S. pneumoniae that triggers the
cascade leading to competence for genetic transformation
(C Hauser 2012, unpublished data). However, pre-incubation
with AliB-like ORF 1 ligand increased the competence response
to CSP 2 to a significantly greater extent in the wild-type strain
110.58 than in the DORF 1 mutant. (The increase in relative
ssbB expression in the DORF 1 mutant with ORF 1 ligand is
equivalent to that observed with a negative control peptide of
unrelated sequence, data not shown.)
The effect of the ligands on growth of the wild-type strain
and its mutants was also tested by exposing the bacteria to the
free peptides, but no effectwas observed (electronic supplemen-
tary material, figure S4). We also tested whether ORF 1 ligand
had any effect on expression of aliB-like ORF 1 or 2 at different
stages of thegrowth curve, but found it hadnone (electronic sup-
plementary material, figure S5). We therefore went on to test
whether culture with E. coli bacteria (in which the ORF 1
ligand is found within the 50S ribosomal subunit protein L4)
affected growth of the pneumococci. Figure 4 shows that E. coli
did indeed have a significant inhibitory effect on growth
which depended on the presence of AliB-like ORF 1. In the
mutants lacking AliB-like ORF 1 E. coli increased growth, an
effect which was also seen, to a lesser extent, in the laboratory
pneumococci strain R6 which also lacks AliB-like ORF 1.
AliB-like ORF 2 protein bound ligands that matched pep-
tides of the nasopharyngeal commensal species Prevotella, a
frequent component of the human nasopharyngeal microbiota.
When we compared adherence of wild-type strain 110.58 and
mutant DORF 1 þ 2 to Detroit 562 human nasopharyngeal epi-
thelial cells we found a slightly (non-significant, p¼ 0.13)
greater adherence for the wild-type strain (figure 5), and so we
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Figure 3. Competence gene expression and transformation. (a) Percentage
transformation rates of strain 110.58 and its mutants DORF 1 þ 2, DORF
1 and DORF 2, showing the mean of three independent experiments.
Error bars show s.e.m. *p ¼ 0.0058, **p ¼ 0.0022, ***p, 0.0001. (b)
The synergistic effect of pre-incubation with 100 mg ml21 AliB-like ORF 1
ligand (SETTFGRDFN) on CSP 2-mediated competence induction was deter-
mined by measuring the expression of late competence gene ssbB using a
transcriptional fusion of the ssbB promoter region with the luciferase
gene, displayed as AUC of the luminescence signal. Results represent three
experiments and show s.e.m. For each strain, the expression of ssbB in the
presence of ORF 1 ligand is presented as a fold difference compared with
the expression value of that strain in the absence of the ORF 1 ligand.
*p ¼ 0.0311.
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Figure 4. Effect of incubation with E. coli on pneumococcal growth. The
wild-type strain 110.58 and its mutants, as well as the control laboratory
strain R6, were assessed for growth in the presence and absence of E. coli
bacteria by quantifying colony forming units (cfu). Data represent the
mean of three independent experiments. Error bars show s.e.m. *p, 0.05.
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Figure 5. Adherence to Detroit 562 nasopharyngeal epithelial cells. The number
of adhered bacteria per Detroit cell was counted by microscopy following Giemsa
staining. Data represent the mean of four independent experiments. Error bars
show s.e.m.
2.0
2.5
3.0
3.5
4.0
4.5
0 1 2 3 4 5 6 7
days post-inoculation
lo
g 1
0 
cf
u/
m
l
110.58
DORF 1+2
DORF 1
DORF 2
Figure 6. Colonization of the nasopharynx of female MF1 mice. Quantification
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colonization in vivo. We measured colonization of the mouse
nasopharynx for wild-type strain 110.58 and its ORF 1 and
ORF 2mutants. At 20 min post-inoculation, there was no differ-
ence in nasopharyngeal colonization between any of the strains;
however at 24 and 48 h, there was significantly (p, 0.05) less
colonization by the DORF 1 þ 2 and DORF 2 mutants than the
wild-type strain 110.58 (figure 6). By day 7, the differences had
disappeared. There was no significant difference in colonization
between the wild-type strain and DORF 1.of bacterial load in the nasopharynx at different timepoints post-inoculation was
determined by plating out dilutions of nasopharyngeal tissue homogenate and
counting the number of colony-forming units for the wild-type strain 110.58
(solid lines with circles), its mutant lacking the aliB-like ORFs (DORF 1+ 2)
(dashed lines with squares), DORF 1 (solid line with triangles) and DORF 2
(dotted lines with inverted triangles). All data derive from five mice per time-
point per strain tested. Data are expressed as mean log10 cfu/ml nasopharyngeal
tissue+ s.e.m.5. Discussion
We aimed to determine whether there is evidence for inter-
species communication between bacteria that live in the
human nasopharynx. We found that S. pneumoniae are able
to recognize and respond to peptides matching other
bacterial species.
We identified short peptide fragments that, via their recep-
tors AliB-like ORF 1 and ORF 2, may mediate responses to the
microbial environment. Peptide fragments that indicated the
presence of Enterobacteriaceae facilitated an upregulation
of competence for genetic transformation. Secreted proteins ofE. coli include ribosomal associated proteins of the 50S riboso-
mal subunit [26]. Therefore, such proteins may have a role in
communication as well as ribosome function and assembly
[27]. Prudhomme et al. [7] showed that low concentrations of
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an upregulation of spontaneous competence, and they
compared this to the SOS response in E. coli induced by the
DNA-damaging agent mitomycin C and by fluoroquinolones.
Here,we propose that when the peptide fragment of Enterobac-
teriaceae binds to AliB-like ORF 1 protein it triggers a similar
stress response, which manifests itself as a synergistic increase
in competence. This would allow the pneumococci to take up
DNA that could give it an advantage in terms of adapting to
the stressful environment. A difference between our finding
and that of Prudhomme et al. is that they found that antibiotics
were sufficient alone to stimulate the competence response. By
contrast, to observe the effect of peptide on competence, we
needed to supply exogenous CSP. This indicates that in nature
another signal is required to induce the stress response leading
to competence. Streptococcus pneumoniae spontaneously release
CSP and so maybe local concentrations of CSP and peptide
would be enough to start the competence cascade. Alterna-
tively, binding of other signals to their receptors could act
synergistically with the binding of peptide to AliB-like ORF 1
protein to initiate the stress response.
We did not find an effect of freeORF 1 ligand on growth but
when E. coli (which produce the ORF 1 ligand) were cultured
together with the pneumococci they inhibited the pneumococ-
cal growth, and thiswas dependent on the presence of AliB-like
ORF 1. We speculate that in the nasopharynx, detection
of Enterobacteriaceae may trigger S. pneumoniae that have
AliB-like ORF 1 to stop growing and become competent.
We propose that when S. pneumoniae bind peptides from
Prevotella species via AliB-like ORF 2 this triggers S. pneumoniae
to promote colonization of the mucosa and may decrease com-
petence for genetic transformation. This is supported by the fact
that in our mouse nasopharyngeal colonization experiments,
knocking out AliB-like ORF 2 reduced colonization at the
early timepoints. Although we did not find a significant differ-
ence in adherence to epithelial cells in vitro, the adherence of the
wild-type strain was slightly greater than that of the mutant
lacking the AliB-like ORFs and so we speculate that the differ-
ence in early colonization efficiency in vivo could be related to
an advantage in adherence for bacteria possessing AliB-like
ORF 2. Alternatively, or in addition, another possibility is that
signalling via AliB-like ORF 2 might stimulate growth at the
early stages of colonization. The results indicate some flexibilityin the peptide length that AliB-like ORF 2 protein can bind as
long as the ligand sequence is present. This would be relevant
if Prevotella releases a mixture of peptides of differing lengths.
Bacteria with the ability to sense a favourable environment
with normal commensal species present might bewell adapted
to a commensal lifestyle.
An indication that AliB-like ORF 1 and ORF 2 may have a
rolewider than that shownhere in non-encapsulated S. pneumo-
niae is that these genes are also found in strainsof the commensal
streptococci S. oralis, S. mitis and S. pseudopneumoniae [28–30].
The entire aliB-like ORF 2 is also found within the capsule
operon of S. pneumoniae serotypes 25a, 25f and 38 and an
aliB-like ORF 2 fragment in 66 other serotypes [31]. Although
AliB-like ORF 1 and ORF 2 are predominantly found in non-
encapsulatedS. pneumoniae and in commensals, theyare homol-
ogues ofAmiA,AliAandAliB of theAmi-AliA/AliB permease,
found in all S. pneumoniae strains [16]. We therefore speculate
that AmiA, AliA and AliB may also be involved in interspecies
bacterial communication, but this remains to be tested.
In this study, we found that AliB-like ORF 1 andORF 2 pro-
teins of S. pneumoniae bacteria bind short peptides matching
sequences found in other bacterial species. Binding results in
phenotypic changes indicating adaptation to the microbial
community. AliB-like ORF 1 protein binds a peptide found in
Enterobacteriaceae, bacteria only expected to be present in an
unhealthy nasopharynx, indicating a stressful environment
and triggering an increase in competence for genetic trans-
formation. AliB-like ORF 2 protein binds a peptide found in
Prevotella which might indicate a normal nasopharyngeal
microbial community, triggering colonization.
We therefore propose that sensing of short peptides is a
newly described mechanism which could be employed by
bacteria to sense neighbouring species in the microbiota
and adapt accordingly. Manipulation of this communication
could be a new target in the control of bacterial colonization
and infections.Acknowledgements. We thank Dimitrios Fotiadis for helpful discussions
and Jean-Pierre Claverys, AndrewMacpherson, Siegfried Hapfelmeier
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